Publications by authors named "David J Sutton"

Claim this Profile
F
Fatal drug reaction to andexanet alfa: a case report.
Richard J Buka, Mamidipudi T Krishna, David J Sutton

EJHaem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate.
Richard J Buka, David J Sutton, Phillip Lr Nicolson

J Thromb Thrombolysis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How will UK hospitals use andexanet alfa? A review of local protocols.
Paula Glancy, David J Sutton, Keith Gomez, Phillip L R Nicolson, Richard J Buka

EJHaem· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DOACs for VTE in patients with brain cancer and brain metastases: choices, choices, choices.
Richard J Buka, David J Sutton

Blood Adv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer is not a single disease: is it safe to extrapolate evidence from trials of direct oral anticoagulants in cancer-associated venous thromboembolism to patients with haematological malignancies?
Richard J Buka, Deepak Chandra, David J Sutton

Br J Haematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatiotemporal competition and task-relevance shape the spatial distribution of emotional interference during rapid visual processing: Evidence from gaze-contingent eye-tracking.
Briana L Kennedy, Daniel Pearson, David J Sutton, Tom Beesley, Steven B Most

Atten Percept Psychophys· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and support for a One Health program for canine vaccination as the most cost-effective means of controlling zoonotic rabies in endemic settings.
Robert P Lavan, Alasdair I MacG King, David J Sutton, Kaan Tunceli

Vaccine· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermotolerance of an inactivated rabies vaccine for dogs.
Felix J Lankester, Pieter A W M Wouters, Anna Czupryna, Guy H Palmer, Imam Mzimbiri, David J Sutton

Vaccine· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined administration in a single injection of a feline multivalent modified live vaccine against FHV, FCV, and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogens.
Theo Kanellos, David J Sutton, Claire F Salisbury, William Stuart K Chalmers

J Feline Med Surg· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine with a chlamydial component.
Chantal Brunner, Theo Kanellos, Marina L Meli, David J Sutton, Ricarda Gisler

Vaccine· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis